Read in Spanish
A group of patients with rheumatoid arthritis had a significant improvement in their disease after consuming a cannabis extract with equal amounts of tetrahydrocannabinol (THC) and cannabidiol (CBD).
The study published in the Journal of Rheumatology took a sample of 58 patients of which 31 received cannabis and 27 placebo. Participants took up to 6 daily doses of a medication known as Sativex with 2.5 mg of THC and 2.5 mg of CBD.
“It was found that patients who took Sativex had a significant improvement in pain, rest, sleep quality and inflammation,” the study notes.
There was no visible effect on morning stiffness, however, markers remained low.
The majority of adverse effects were moderate, but no type of effect was found related to the decrease in the improvement in the group.
The researchers concluded that the drug was more effective than the placebo that was given to the other group of patients.
“A significant analgesic effect and of the suppressed disease was observed when using the Sativex treatment. Although the differences are not so marked within the population, the improvements represent benefits of clinical relevance and indicate that more detailed information is needed “.
Read the study at the following link: https://www.ncbi.nlm.nih.gov/pubmed/16282192
–
Follow us on Instagram
https://www.facebook.com/mccrorg/videos/1531351230271998/
in Costa Rica. 
